Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 9/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 3/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrogen Sulfide SCHEMBL29150228 | 0.98 | TSHR (0.56) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL29737739 | 0.98 | TSHR (0.61) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL29737736 | 0.98 | TSHR (0.61) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL16286988 | 0.98 | TSHR (0.61) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL10601643 | 0.98 | TSHR (0.61) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL29005318 | 0.98 | TSHR (0.61) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL1219310 | 0.98 | TSHR (0.61) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL16536830 | 0.98 | TSHR (0.61) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL29737743 | 0.98 | TSHR (0.61) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL16286606 | 0.98 | TSHR (0.61) | TSHRALDH1A1CYP3A4HPGDTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 402 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107664919-B | Method for producing patterned cured product and patterned cured product obtained thereby | 三星显示有限公司 | 2022-10-14 | — | — | CN | claimed |
| CN-113354783-A | Toughened thermoplastic material and preparation method and application thereof | 中国科学院化学研究所 | 2021-09-07 | — | — | CN | claimed |
| US-10744684-B2 | Method of preparing patterned cured product and patterned cured product obtained using the method | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-08-18 | — | — | US | claimed |
| CN-107664919-A | Prepare the method for patterning cured article and thus obtained patterning cured article | 三星显示有限公司 | 2018-02-06 | — | — | CN | claimed |
| US-20180029255-A1 | METHOD OF PREPARING PATTERNED CURED PRODUCT AND PATTERNED CURED PRODUCT OBTAINED USING THE METHOD | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-02-01 | — | — | US | claimed |
| US-20050048200-A1 | PROCESS FOR PREPARING AN OPTICAL WAVEGUIDE COMPONENT FROM ACRYLATE/TITANIUM ALKOXIDE COMPOSITE MATERIAL AND THE PREPARED OPTICAL WAVEGUIDE COMPONENT | CHANG CHUN PLASTICS CO., LTD. (TW) | 2005-03-03 | — | — | US | claimed |
| US-6852358-B1 | Process for preparing an optical waveguide component from acrylate/titanium alkoxide composite material and the prepared optical waveguide component | CHANG CHUN PLASTICS CO., LTD. (TW) | 2005-02-08 | — | — | US | claimed |
| US-20260049203-A1 | CURABLE COMPOSITION | KANEKA NORTH AMERICA LLC (US) | 2026-02-19 | — | — | US | disclosed |
| EP-4563609-A1 | PHOTOCURABLE COMPOSITION, CURED PRODUCT OF SAME, AND COATED ARTICLE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-06-04 | — | — | EP | disclosed |
| US-12319815-B2 | Resin composition, method for producing same, and multi-liquid curable resin composition | KANEKA CORPORATION (JP) | 2025-06-03 | — | — | US | disclosed |
| US-20250171657-A1 | HARDCOAT FILM AND ARTICLE AND IMAGE DISPLAY DEVICE HAVING HARDCOAT FILM | FUJIFILM CORPORATION (JP) | 2025-05-29 | — | — | US | disclosed |
| EP-4556497-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING COPOLYMER | AGC INC. (JP) | 2025-05-21 | — | — | EP | disclosed |
| EP-4556498-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING COPOLYMER | AGC INC. (JP) | 2025-05-21 | — | — | EP | disclosed |
| EP-1099728-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2001-05-16 | — | — | EP | disclosed |
| EP-1004628-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2000-05-31 | — | — | EP | disclosed |
| US-6020446-A | Curable composition | KANEKA CORPORATION (JP) | 2000-02-01 | — | — | US | disclosed |
| EP-0934984-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 1999-08-11 | — | — | EP | disclosed |
| EP-0934956-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 1999-08-11 | — | — | EP | disclosed |
| EP-0931821-A2 | Primer composition and method of effecting adhesion for sealing compositions | KANEKA CORPORATION (JP) | 1999-07-28 | — | — | EP | disclosed |
| US-4432877-A | Organo-mercurial materials | NEW ENGLAND NUCLEAR CORPORATION (US) | 1984-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049203-A1 | CURABLE COMPOSITION | FLNA, FLNB, FSCN1 | TSHR 1898/4885ALDH1A1 3439/4885CYP3A4 4344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.